{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AT1 receptor", "Angiotensin 1-7", "Breast cancer", "Losartan", "Mas receptor", "Renin-angiotensin system", "Sertraline"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38831897", "DateRevised": {"Year": "2024", "Month": "06", "Day": "07"}, "Article": {"Language": ["eng"], "ELocationID": ["101738", "10.1016/j.bbrep.2024.101738"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "23"}], "Journal": {"ISSN": "2405-5808", "JournalIssue": {"Volume": "38", "PubDate": {"Year": "2024", "Month": "Jul"}}, "Title": "Biochemistry and biophysics reports", "ISOAbbreviation": "Biochem Biophys Rep"}, "ArticleTitle": "Modulation of ACE2/Ang1-7/Mas and ACE/AngII/AT1 axes affects anticancer properties of sertraline in MCF-7 breast cancer cells.", "Pagination": {"StartPage": "101738", "MedlinePgn": "101738"}, "Abstract": {"AbstractText": ["The renin-angiotensin system (RAS) is best known for playing a major role in maintaining the physiology of the cardiovascular system. Dysregulation of the RAS pathway has been proposed as a link to some malignancies and contributes to cancer metastasis. Breast cancer is considered as one of the leading causes of cancer death in women and its prevention remains yet a challenge. Elements of RAS are expressed in both normal breast tissue and cancerous cells, signifying the essential role of RAS in breast cancer pathology. Sertraline, a widely used antidepressant, has shown anti-proliferative properties on a variety of malignancies. This study aimed to investigate the effect of sertraline and its combination with agonists and antagonists of RAS (A779, Ang 1-7 and losartan) on viability of MCF-7\u00a0cells along with their effect on apoptosis and distribution of cell cycle. Our results indicated that sertraline, losartan and Ang 1-7 significantly decreased cell viability, induced apoptosis and cell cycle arrest. A779 blunted the effect of sertraline on cell viability, ROS generation and cell cycle arrest. Combination treatment of sertraline with losartan as well as Ang 1-7 caused a remarkable decline in cell viability. In conclusion, results of the present study support the anti-cancer properties of sertraline, losartan and Ang 1-7 via induction of apoptosis and cell cycle arrest."], "CopyrightInformation": "\u00a9 2024 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology & Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Fatehi", "ForeName": "Reihaneh", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Comittee, Shiraz University of Medical Sciences, Shiraz, Iran."}, {"Identifier": [], "Affiliation": "Department of Pharmacology & Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Nouraei", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Comittee, Shiraz University of Medical Sciences, Shiraz, Iran."}, {"Identifier": [], "Affiliation": "Department of Pharmacology & Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Panahiyan", "ForeName": "Morteza", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology & Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran."}, {"Identifier": [], "Affiliation": "Food and Supplements Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}, {"Identifier": [], "Affiliation": "Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Rashedinia", "ForeName": "Marzieh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology & Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Firouzabadi", "ForeName": "Negar", "Initials": "N"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Biochem Biophys Rep", "NlmUniqueID": "101660999", "ISSNLinking": "2405-5808"}, "CoiStatement": "The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Negar Firouzabadi reports financial support was provided by 10.13039/501100004320Shiraz University of Medical Sciences. Dr. Negar Firouzabadi reports a relationship with 10.13039/501100004320Shiraz University of Medical Sciences that includes: funding grants. None declared. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Crowley S.D., Coffman T.M. Recent advances involving the renin\u2013angiotensin system. Experimental cell research. 2012;318(9):1049\u20131056.", "ArticleIdList": ["PMC3625040", "22410251"]}, {"Citation": "Domi\u0144ska K., Ok\u0142a P., Kowalska K., Habrowska-G\u00f3rczy\u0144ska D.E., Urbanek K.A., Och\u0119dalski T., et al. Influence and mechanism of Angiotensin 1-7 on biological properties of normal prostate epithelial cells. Biochemical and biophysical research communications. 2018;502(1):152\u2013159.", "ArticleIdList": ["29802847"]}, {"Citation": "Arrieta O., Villarreal-Garza C., Vizca\u00edno G., Pineda B., Hernandez-Pedro N., Guevara-Salazar P., et al. Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer. Tumor Biol. 2015;36:5627\u20135634.", "ArticleIdList": ["25682288"]}, {"Citation": "Domi\u0144ska K., Och\u0119dalski T., Kowalska K., Matysiak-Burzy\u0144ska Z.E., P\u0142uciennik E., Piastowska-Ciesielska A.W. Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells. Int. J. Oncol. 2016;48(6):2619\u20132628.", "ArticleIdList": ["27035428"]}, {"Citation": "Beyazit F., Ayhan S., Celik H.T., Gungor T. Assessment of serum angiotensin-converting enzyme in patients with epithelial ovarian cancer. Arch. Gynecol. Obstet. 2015;292:415\u2013420.", "ArticleIdList": ["25693759"]}, {"Citation": "Almutlaq M., Alamro A.A., Alamri H.S., Alghamdi A.A., Barhoumi T. The effect of local renin angiotensin system in the common types of cancer. Front. Endocrinol. 2021;12", "ArticleIdList": ["PMC8446618", "34539580"]}, {"Citation": "de Miranda F.S., Guimar\u00e3es J.P.T., Menikdiwela K.R., Mabry B., Dhakal R., layeequr Rahman R., et al. Breast cancer and the renin-angiotensin system (RAS): therapeutic approaches and related metabolic diseases. Mol. Cell. Endocrinol. 2021;528", "ArticleIdList": ["33753205"]}, {"Citation": "Bujak-Gizycka B., Madej J., Bystrowska B., Toton-Zuranska J., Kus K., Kolton-Wroz M., et al. Angiotensin 1-7 formation in breast tissue is attenuated in breast cancer-a study on the metabolism of angiotensinogen in breast cancer cell lines. J. Physiol. Pharmacol. 2019;70(4):503\u2013514.", "ArticleIdList": ["31642813"]}, {"Citation": "Rasha F., Ramalingam L., Gollahon L., Rahman R.L., Rahman S.M., Menikdiwela K., et al. Mechanisms linking the renin-angiotensin system, obesity, and breast cancer. Endocr. Relat. Cancer. 2019;26(12):R653\u2013R672.", "ArticleIdList": ["31525726"]}, {"Citation": "Ekambaram P., Lee J.-Y., Hubel N.E., Hu D., Yerneni S., Campbell P.G., et al. The CARMA3\u2013Bcl10\u2013MALT1 Signalosome drives NF\u03baB activation and promotes aggressiveness in angiotensin II receptor\u2013positive breast cancer. Cancer Res. 2018;78(5):1225\u20131240.", "ArticleIdList": ["PMC6436094", "29259013"]}, {"Citation": "Acconcia F. The network of angiotensin receptors in breast cancer. Cells. 2020;9(6):1336.", "ArticleIdList": ["PMC7349848", "32471115"]}, {"Citation": "Domi\u0144ska K., Ok\u0142a P., Kowalska K., Habrowska-G\u00f3rczy\u0144ska D.E., Urbanek K.A., Och\u0119dalski T., et al. Angiotensin 1\u20137 modulates molecular and cellular processes central to the pathogenesis of prostate cancer. Sci. Rep. 2018;8(1)", "ArticleIdList": ["PMC6202343", "30361641"]}, {"Citation": "Pei N., Wan R., Chen X., Li A., Zhang Y., Li J., et al. Angiotensin-(1-7) decreases cell growth and angiogenesis of human nasopharyngeal carcinoma XenograftsAng-(1-7) inhibits proliferation of NPC cells. Mol. Cancer Therapeut. 2016;15(1):37\u201347.", "ArticleIdList": ["26671566"]}, {"Citation": "Krishnan B., Torti F.M., Gallagher P.E., Tallant E.A. Angiotensin\u2010(1\u20107) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt\u20101. Prostate. 2013;73(1):60\u201370.", "ArticleIdList": ["22644934"]}, {"Citation": "Qian Y.-R., Guo Y., Wan H.-Y., Fan L., Feng Y., Ni L., et al. Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition. Oncol. Rep. 2013;29(6):2408\u20132414.", "ArticleIdList": ["23545945"]}, {"Citation": "Menon J., Soto-Pantoja D.R., Callahan M.F., Cline J.M., Ferrario C.M., Tallant E.A., et al. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res. 2007;67(6):2809\u20132815.", "ArticleIdList": ["17363603"]}, {"Citation": "Cambados N., Walther T., Nahmod K., Tocci J.M., Rubinstein N., B\u00f6hme I., et al. Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells. Oncotarget. 2017;8(51)", "ArticleIdList": ["PMC5687620", "29179450"]}, {"Citation": "Yu C., Tang W., Wang Y., Shen Q., Wang B., Cai C., et al. Downregulation of ACE2/Ang-(1\u20137)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry. Cancer letters. 2016;376(2):268\u2013277.", "ArticleIdList": ["27063099"]}, {"Citation": "Bahramali E., Firouzabadi N., Yavarian I., Shayesteh M.R.H., Erfani N., Shoushtari A.A., et al. Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial. Eur. J. Clin. Pharmacol. 2016;72(9):1059\u20131064.", "ArticleIdList": ["27262302"]}, {"Citation": "Boia-Ferreira M., Bas\u00edlio A., Hamasaki A., Matsubara F., Appel M., Da Costa C., et al. TCTP as a therapeutic target in melanoma treatment. Br. J. Cancer. 2017;117(5):656\u2013665.", "ArticleIdList": ["PMC5572181", "28751755"]}, {"Citation": "Chinnapaka S., Bakthavachalam V., Munirathinam G. Repurposing antidepressant sertraline as a pharmacological drug to target prostate cancer stem cells: dual activation of apoptosis and autophagy signaling by deregulating redox balance. Am. J. Cancer Res. 2020;10(7):2043.", "ArticleIdList": ["PMC7407340", "32775000"]}, {"Citation": "Drinberg V., Bitcover R., Rajchenbach W., Peer D. Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine. Cancer letters. 2014;354(2):290\u2013298.", "ArticleIdList": ["25173796"]}, {"Citation": "Huang J.K., Chang H.T., Chou C.T., Shu S.S., Kuo C.C., Tsai J.Y., et al. The mechanism of sertraline\u2010induced [Ca2+] i rise in human PC3 prostate cancer cells. Basic Clin. Pharmacol. Toxicol. 2011;109(2):103\u2013110.", "ArticleIdList": ["21371263"]}, {"Citation": "Duarte D., Vale N. Antidepressant drug sertraline against human cancer cells. Biomolecules. 2022;12(10):1513.", "ArticleIdList": ["PMC9599050", "36291722"]}, {"Citation": "Wang G., Gong Y., Burczynski F.J., Hasinoff B.B. Cell lysis with dimethyl sulphoxide produces stable homogeneous solutions in the dichlorofluorescein oxidative stress assay. Free Radic. Res. 2008;42(5):435\u2013441.", "ArticleIdList": ["18484276"]}, {"Citation": "Fatehi R., Rashedinia M., Akbarizadeh A.R., Firouzabadi N. Metformin enhances anti-cancer properties of resveratrol in MCF-7 breast cancer cells via induction of apoptosis, autophagy and alteration in cell cycle distribution. Biochem. Biophys. Res. Commun. 2023;644:130\u2013139.", "ArticleIdList": ["36641965"]}, {"Citation": "Xia D., Zhang Y.-T., Xu G.-P., Yan W.-W., Pan X.-R., Tong J.-H. Sertraline exerts its antitumor functions through both apoptosis and autophagy pathways in acute myeloid leukemia cells. Leuk. Lymphoma. 2017;58(9):2208\u20132217.", "ArticleIdList": ["28278721"]}, {"Citation": "Geeraerts S.L., Kampen K.R., Rinaldi G., Gupta P., Planque M., Louros N., et al. Repurposing the antidepressant sertraline as SHMT inhibitor to suppress serine/glycine synthesis\u2013addicted breast tumor growth. Mol. Cancer Therapeut. 2021;20(1):50\u201363.", "ArticleIdList": ["PMC7611204", "33203732"]}, {"Citation": "Oh E., Kim J.Y., Cho Y., An H., Lee N., Jo H., et al. Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial\u2013mesenchymal transition and promotes tumor growth and angiogenesis. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2016;1863(6):1071\u20131081.", "ArticleIdList": ["26975580"]}, {"Citation": "Reddy K.K., Lefkove B., Chen L.B., Govindarajan B., Carracedo A., Velasco G., et al. The antidepressant sertraline downregulates Akt and has activity against melanoma cells. Pigment cell & melanoma research. 2008;21(4):451\u2013456.", "ArticleIdList": ["18710373"]}, {"Citation": "Tzadok S., Beery E., Israeli M., Uziel O., Lahav M., Fenig E., et al. In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells. Int. J. Oncol. 2010;37(4):1043\u20131051.", "ArticleIdList": ["20811727"]}, {"Citation": "Gallagher P.E., Tallant E.A. Inhibition of human lung cancer cell growth by angiotensin-(1-7) Carcinogenesis. 2004;25(11):2045\u20132052.", "ArticleIdList": ["15284177"]}, {"Citation": "Liu Y., Li B., Wang X., Li G., Shang R., Yang J., et al. Angiotensin-(1\u20131) suppresses hepatocellular carcinoma growth and angiogenesis via complex interactions of angiotensin II type 1 receptor, angiotensin II type 2 receptor and Mas receptor. Mol. Med. 2015;21:626\u2013636.", "ArticleIdList": ["PMC4656199", "26225830"]}, {"Citation": "Luo Y., Tanabe E., Kitayoshi M., Nishiguchi Y., Fujiwara R., Matsushima S., et al. Expression of MAS 1 in breast cancer. Cancer Sci. 2015;106(9):1240\u20131248.", "ArticleIdList": ["PMC4582995", "26080617"]}, {"Citation": "Lin Y.-T., Wang H.-C., Chuang H.-C., Hsu Y.-C., Yang M.-Y., Chien C.-Y. Pre-treatment with angiotensin-(1\u20137) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts. J. Mol. Med. 2018;96:1407\u20131418.", "ArticleIdList": ["PMC7095977", "30374682"]}, {"Citation": "Sun H., Li T., Zhuang R., Cai W., Zheng Y. Do renin\u2013angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: evidence from a meta-analysis including 55 studies. Medicine. 2017;96(13)", "ArticleIdList": ["PMC5380250", "28353566"]}, {"Citation": "Shen J., Huang Y.-M., Wang M., Hong X.-Z., Song X.-N., Zou X., et al. Renin\u2013angiotensin system blockade for the risk of cancer and death. J. Renin-Angiotensin-Aldosterone Syst. JRAAS. 2016;17(3)", "ArticleIdList": ["PMC5843874", "27402638"]}, {"Citation": "Lin K.-L., Chi C.-C., Lu T., Tseng L.-L., Wang J.-L., Lu Y.-C., et al. Effect of sertraline on [Ca2+] i and viability of human MG63 osteosarcoma cells. Drug Chem. Toxicol. 2013;36(2):231\u2013240.", "ArticleIdList": ["22931138"]}, {"Citation": "Then C.-K., Liu K.-H., Liao M.-H., Chung K.-H., Wang J.-Y., Shen S.-C. Antidepressants, sertraline and paroxetine, increase calcium influx and induce mitochondrial damage-mediated apoptosis of astrocytes. Oncotarget. 2017;8(70)", "ArticleIdList": ["PMC5777788", "29383176"]}, {"Citation": "Saadaldin Alkasso R.A., Abdullah Al Neaimy KS. The effect of sertraline on oxidative stress in patients with depression. Mosul Journal of Nursing. 2021;9(2):148\u2013156."}, {"Citation": "Figueiredo V.P., Barbosa M.A., de Castro U.G.M., Zacarias A.C., Bezerra F.S., de S\u00e1 R.G., et al. Antioxidant effects of oral ang-(1-7) restore insulin pathway and RAS components ameliorating cardiometabolic disturbances in rats. Oxid. Med. Cell. Longev. 2019;2019", "ArticleIdList": ["PMC6664692", "31396301"]}, {"Citation": "Zhang F., Liu C., Wang L., Cao X., Wang Y.Y., Yang J.K. Antioxidant effect of angiotensin (1-7) in the protection of pancreatic \u03b2 cell function. Mol. Med. Rep. 2016;14(3):1963\u20131969.", "ArticleIdList": ["PMC4991744", "27430410"]}, {"Citation": "Gil-Ad I., Zolokov A., Lomnitski L., Taler M., Bar M., Luria D., et al. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice. Int. J. Oncol. 2008;33(2):277\u2013286.", "ArticleIdList": ["18636148"]}, {"Citation": "Mu C., Peng R.-K., Guo C.-L., Li A., Yang X.-M., Zeng R., et al. Discovery of sertraline and its derivatives able to combat drug-resistant gastric cancer cell via inducing apoptosis. Bioorg. Med. Chem. Lett. 2021;41", "ArticleIdList": ["33775839"]}, {"Citation": "Chen S., Xuan J., Wan L., Lin H., Couch L., Mei N., et al. Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol. Sci. 2014;137(2):404\u2013415.", "ArticleIdList": ["24194395"]}, {"Citation": "Zinnah K.M.A., Seol J.W., Park S.Y. Inhibition of autophagy flux by sertraline attenuates TRAIL resistance in lung cancer via death receptor 5 upregulation. Int. J. Mol. Med. 2020;46(2):795\u2013805.", "ArticleIdList": ["PMC7307864", "32626921"]}, {"Citation": "Jiang X., Lu W., Shen X., Wang Q., Lv J., Liu M., et al. Repurposing sertraline sensitizes non\u2013small cell lung cancer cells to erlotinib by inducing autophagy. JCI insight. 2018;3(11)", "ArticleIdList": ["PMC6124398", "29875309"]}, {"Citation": "Lin Y.T., Wang H.C., Tsai M.H., Su Y.Y., Yang M.Y., Chien C.Y. Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma. Cancer. 2021;127(10):1606\u20131619.", "ArticleIdList": ["33405241"]}, {"Citation": "Takagi H., Kaji K., Nishimura N., Ishida K., Ogawa H., Takaya H., et al. The angiotensin II receptor blocker losartan sensitizes human liver cancer cells to lenvatinib-mediated cytostatic and angiostatic effects. Cells. 2021;10(3):575.", "ArticleIdList": ["PMC8001516", "33807929"]}, {"Citation": "Hashemzehi M., Rahmani F., Khoshakhlagh M., Avan A., Asgharzadeh F., Barneh F., et al. Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer. Excli Journal. 2021;20:506.", "ArticleIdList": ["PMC8056058", "33883980"]}]}], "History": [{"Year": "2024", "Month": "2", "Day": "12"}, {"Year": "2024", "Month": "5", "Day": "13"}, {"Year": "2024", "Month": "5", "Day": "20"}, {"Year": "2024", "Month": "6", "Day": "4", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "6", "Day": "4", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "6", "Day": "4", "Hour": "3", "Minute": "37"}, {"Year": "2024", "Month": "5", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["38831897", "PMC11145238", "10.1016/j.bbrep.2024.101738", "S2405-5808(24)00102-X"]}}]}